Michael Farber

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Bunge Limited Finance Corp., a wholly owned subsidiary of Bunge Limited, of $600…

Davis Polk advised the joint book-running managers in connection with a $575 million SEC-registered debt offering by Flex Ltd. The offering consisted of $250 million aggregate…

Davis Polk advised the representatives of the several underwriters in connection with the $204 million follow-on offering of 2,415,000 shares of common stock of Overstock.com, Inc.,…

Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $750 million aggregate principal amount of floating-rate medium-term notes Series B due…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Wix.com Ltd. of $575 million aggregate principal amount of its 0%…

Davis Polk advised the initial purchasers on a Rule 144A and Regulation S reopening of $50 million aggregate principal amount of 7.500% senior secured notes due 2028 of AI Candelaria …

Davis Polk advised the representatives of the underwriters in connection with an approximately $963.5 million public offering of ordinary shares of Horizon Therapeutics Public Limited…

Davis Polk advised the sole bookrunning manager on an SEC-registered offering by Schlumberger Investment SA of $350 million aggregate principal amount of 2.650% senior notes due 2030. The…

Davis Polk advised the joint book-running managers on an SEC-registered debt offering by Alphabet Inc., consisting of $1 billion of 0.450% notes due 2025, $1 billion of 0.800% notes…

Davis Polk advised the underwriters in connection with an initial public offering of 11,000,000 shares of common stock of Nurix Therapeutics, Inc. at $19 per share, for total gross proceeds…